National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Keytruda® is indicated for the first line treatment of unresectable or advanced metastatic melanoma in adults.

Rapid Review

Commenced Completed Outcome
06/08/2015 13/08/2015 Full Pharmacoeconomic Evaluation Recommended

Pharmacoeconomic Evaluation

Commenced Completed Outcome
02/11/2015  08/02/2016 Reimbursement Recommended

Summary